Patient Compliance

The regulator made the change after about 1,000 patients lost access to the drug through their other care providers

British Columbia says it will save more than $96 million in its prescription drug program by expanding the use of so-called biosimilar drugs to treat diabetes, arthritis and Crohn's disease.

Orthorexia tends to go overlooked because many people with the condition are physically healthy, even though they may be suffering psychologically